Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).
about
Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study.
P2860
Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Identification of major factor ...... t generation sequencing (NGS).
@ast
Identification of major factor ...... t generation sequencing (NGS).
@en
type
label
Identification of major factor ...... t generation sequencing (NGS).
@ast
Identification of major factor ...... t generation sequencing (NGS).
@en
prefLabel
Identification of major factor ...... t generation sequencing (NGS).
@ast
Identification of major factor ...... t generation sequencing (NGS).
@en
P2093
P2860
P1433
P1476
Identification of major factor ...... xt generation sequencing (NGS)
@en
P2093
John D Pfeifer
Karen Steger-May
TuDung T Nguyen
P2860
P304
P356
10.1016/J.MOLONC.2015.05.004
P577
2015-05-29T00:00:00Z